Literature DB >> 10318822

Okadaic acid activates atypical protein kinase C (zeta/lambda) in rat and 3T3/L1 adipocytes. An apparent requirement for activation of Glut4 translocation and glucose transport.

M L Standaert1, G Bandyopadhyay, M P Sajan, L Cong, M J Quon, R V Farese.   

Abstract

Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, is known to provoke insulin-like effects on GLUT4 translocation and glucose transport, but the underlying mechanism is obscure. Presently, we found in both rat adipocytes and 3T3/L1 adipocytes that okadaic acid provoked partial insulin-like increases in glucose transport, which were inhibited by phosphatidylinositol (PI) 3-kinase inhibitors, wortmannin and LY294002, and inhibitors of atypical protein kinase C (PKC) isoforms, zeta and lambda. Moreover, in both cell types, okadaic acid provoked increases in the activity of immunoprecipitable PKC-zeta/lambda by a PI 3-kinase-dependent mechanism. In keeping with apparent PI 3-kinase dependence of stimulatory effects of okadaic acid on glucose transport and PKC-zeta/lambda activity, okadaic acid provoked insulin-like increases in membrane PI 3-kinase activity in rat adipocytes; the mechanism for PI 3-kinase activation was uncertain, however, because it was not apparent in phosphotyrosine immunoprecipitates. Of further note, okadaic acid provoked partial insulin-like increases in the translocation of hemagglutinin antigen-tagged GLUT4 to the plasma membrane in transiently transfected rat adipocytes, and these stimulatory effects on hemagglutinin antigen-tagged GLUT4 translocation were inhibited by co-expression of kinase-inactive forms of PKC-zeta and PKC-lambda but not by a double mutant (T308A, S473A), activation-resistant form of protein kinase B. Our findings suggest that, as with insulin, PI 3-kinase-dependent atypical PKCs, zeta and lambda, are required for okadaic acid-induced increases in GLUT4 translocation and glucose transport in rat adipocytes and 3T3/L1 adipocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318822     DOI: 10.1074/jbc.274.20.14074

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.

Authors:  Satoshi Ugi; Takeshi Imamura; Hiroshi Maegawa; Katsuya Egawa; Takeshi Yoshizaki; Kun Shi; Toshiyuki Obata; Yousuke Ebina; Atsunori Kashiwagi; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity.

Authors:  Björn Hartleben; Heiko Schweizer; Pauline Lübben; Malte P Bartram; Clemens C Möller; Ronja Herr; Changli Wei; Elke Neumann-Haefelin; Bernhard Schermer; Hanswalter Zentgraf; Dontscho Kerjaschki; Jochen Reiser; Gerd Walz; Thomas Benzing; Tobias B Huber
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

3.  Regulation of catalase enzyme activity by cell signaling molecules.

Authors:  Sumio Yano; Noriko Yano
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

Review 4.  Cellular location of insulin-triggered signals and implications for glucose uptake.

Authors:  Nish Patel; Carol Huang; Amira Klip
Journal:  Pflugers Arch       Date:  2005-11-12       Impact factor: 3.657

5.  Different protein kinase C isoforms determine growth factor specificity in neuronal cells.

Authors:  K C Corbit; J W Soh; K Yoshida; E M Eves; I B Weinstein; M R Rosner
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.

Authors:  Jacqueline C Shultz; Ngoc Vu; Michael D Shultz; Mba-Uzoma U Mba; Brian A Shapiro; Charles E Chalfant
Journal:  Mol Cancer Res       Date:  2012-04-20       Impact factor: 5.852

7.  Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells.

Authors:  M Mao; X Fang; Y Lu; R Lapushin; R C Bast; G B Mills
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

8.  Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin.

Authors:  June Chunqiu Hou; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

9.  Protein kinase C/zeta (PRKCZ) gene is associated with type 2 diabetes in Han population of North China and analysis of its haplotypes.

Authors:  Yun-Feng Li; Hong-Xia Sun; Guo-Dong Wu; Wei-Nan Du; Jin Zuo; Yan Shen; Bo-Qin Qiang; Zhi-Jian Yao; Heng Wang; Wei Huang; Zhu Chen; Mo-Miao Xiong; Yan Meng; Fu-De Fang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.

Authors:  Stephen A Whelan; Wagner B Dias; Lakshmanan Thiruneelakantapillai; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.